Neurodegenerative Disease
Neurology·MeSH: Neurodegenerative Diseases
6 drugs in development·5 companies·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| latozinemab | Alector, Inc. (ALEC) |
Phase 2(2)
Phase 1(1)
| Drug | Company |
|---|---|
| PRX019 | PROTHENA CORP PUBLIC LTD CO (PRTA) |
Preclinical(2)
Compare drugs
Frequently asked questions
How many drugs are in development for Neurodegenerative Disease?
BioSniper tracks 6 drugs in development for Neurodegenerative Disease across 5 companies.
How many clinical trials target Neurodegenerative Disease?
There are 1 clinical trial targeting Neurodegenerative Disease tracked by BioSniper.
Deep-dive into Neurodegenerative Disease
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis